Fatores associados à ocorrência da neuropatia periférica diabética em pessoas com diabetes mellitus tipo 2

Debora Ellen Sousa Costa; Lívia Maia Pascoal; Marcelino Santos Neto; Jairo Domingos de Morais; Yan Torres Andrade; Ana Clara Laundos Oliveira; Barbara dos Santos Limeira

doi:10.36517/2175-6783.20262796220

Autores

Debora Ellen Sousa Costa Universidade Federal do Maranhão https://orcid.org/0000-0003-4205-8801
Lívia Maia Pascoal Universidade Federal do Maranhão https://orcid.org/0000-0003-0876-3996
Marcelino Santos Neto Universidade Federal do Maranhão https://orcid.org/0000-0002-6105-1886
Jairo Domingos de Morais University for International Integration of the Afro-Brazilian Lusophony https://orcid.org/0000-0002-8383-7871
Yan Torres Andrade Universidade Federal do Maranhão https://orcid.org/0009-0001-4627-2816
Ana Clara Laundos Oliveira Universidade Federal do Maranhão https://orcid.org/0009-0001-9123-6822
Barbara dos Santos Limeira Universidade Federal do Maranhão https://orcid.org/0000-0001-8788-8089

DOI:

https://doi.org/10.36517/2175-6783.20262796220

Palavras-chave:

Neuropatias Diabéticas; Atenção Primária à Saúde; Diabetes Mellitus Tipo 2; Fatores de Risco.

Resumo

Objetivo: identificar fatores associados à ocorrência da neuropatia periférica diabética em pessoas com diabetes mellitus tipo 2. Métodos: estudo transversal realizado com 123 usuários acompanhados em uma Unidade Básica de Saúde. Para análise dos fatores associados, aplicou-se regressão múltipla de Poisson com variância robusta e coeficiente de Spearman para correlação. Resultados: a prevalência de neuropatia periférica diabética foi de 44,7%. A ocorrência da complicação apresentou associação estatisticamente significativa com o estado civil casado/união estável (p=0,048) e viúvo (p=0,015), ensino médio incompleto (p=0,030), presença de dor neuropática (p=0,001) ou dor indeterminada (p=0,001), tempo de diagnóstico do diabetes entre cinco e 10 anos (p=0,031) e superior a 10 anos (p=0,001). Conclusão: fatores sociodemográficos e clínicos influenciaram diretamente a ocorrência da neuropatia periférica diabética. Contribuições para a prática: esses achados reforçam a relevância da Atenção Primária no rastreamento e manejo da neuropatia, destacando a atuação do enfermeiro na prevenção, educação em saúde, vigilância clínica e acompanhamento contínuo.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

1. Eid SA, Rumora AE, Beirowski B, Bennett DL, Hur J, Savelieff MG, et al. New perspectives in diabetic neuropathy. Neuron. 2023;111(17):2623-41. doi: https://doi.org/10.1016/j.neuron.2023.05.003

2. Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, et al. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther. 2025;10(1):132. doi: https://dx.doi.org/10.1038/s41392-025-02175-1

3. American Diabetes Association (ADA). Microvascular complications and foot care: Standards of Medical Care in Diabetes – 2021. Diabetes Care. 2021;44(Suppl 1):151‑67. doi: https://doi.org/10.2337/dc21-S011

4. Goh LH, Siah CJR, Tam WWS, Tai ES, Young DYL. Effectiveness of the chronic care model for adults with type 2 diabetes in primary care: a systematic review and meta-analysis. Syst Rev. 2022;11(1):273. doi: https://dx.doi.org/10.1186/s13643-022-02117-w

5. Silva A, Stival M, Funghetto S, Volpe C, Funez M, Lima L. Comparison of pain and quality of life between individuals with and without diabetic neuropathy. Rev Enferm UFSM. 2021;11:e62. doi: https://doi.org/10.5902/2179769263722

6. Park E, Choi J, Lee S. A nurse‑led telehealth program for diabetes foot care: feasibility and usability study. JMIR Nursing. 2023;6(1):e40000. doi: https://doi.org/10.2196/40000

7. Lopes CGS, Rocha TAH, Thomaz EBAF, Tonello AS, Rocha NCS, Duarte KMM, et al. Diabetes Mellitus macro-regional inequalities in PHC: comparing the three PMAQ-AB cycles. Saúde Debate. 2022; 133(46):376-91. doi: http://dx.doi.org/10.1590/0103-1104202213309i

8. Farias AL, Silva ASA, Tavares VB, Souza JS, Silva HP, Bastos MSCBO, et al. Amazon amandaba—prevalence, risk factors and self-care perception associated with diabetic peripheral neuropathy in patients with type 2 diabetes: a cross-sectional study. Healthcare (Basel). 2023;11(4):518. doi: https://doi.org/10.3390/healthcare11040518

9. Bertolucci PHF, Brucki SMD, Campacci SR, Juliano Y. O Mini‑Exame do Estado Mental em uma população geral: impacto da escolaridade. Arq Neuro‑Psiquiatr. 1994;52(1):1‑7. doi: https://doi.org/10.1590/S0004-282X1994000100001

10. Ministério da Saúde (BR). Sistema de Informação para a Atenção Primária à Saúde (e-SUS) [Internet]. 2025 [cited Oct 17, 2025]. Available from: https://sisaps.saude.gov.br/sistemas/esusaps/

11. Gonçalves H, Lopes A, Costa A, Calvão J, Fonseca L, Gonçalves J, et al. Rastreio de polineuropatia diabética periférica em doentes internados. Rev Med Interna. 2019;26(4):297‑303. doi: https://doi.org/10.24950/rspmi/O/176/19/4/2019

12. Oliveira FB, Botelho KKP, Bezerra AR, Azevedo DIO, Santos-Couto-Paz CC, Fachin-Martins E. Cross-cultural adaptation to Brazilian Portuguese of the Michigan Neuropathy Screening Instrument: MNSI-Brazil. Arq Neuropsiquiatr. 2016;74(8):653-61. doi: http://doi.org/10.1590/0004-282X20160094

13. Rolim LC, Thyssen PJ, Flumignan RLG, Andrade DC, Dib SA. Diagnóstico e tratamento da neuropatia periférica diabética: diretriz oficial da Sociedade Brasileira de Diabetes. 2023. doi: https://doi.org/10.29327/557753.2022-14

14. Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911-20. doi: https://doi.org/10.1185/030079906X132488

15. Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A, More-Yupanqui MD, Osores-Flores M, Espinoza R, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS One. 2021;16(5):e0251642. doi: https://doi.org/10.1371/journal.pone.0251642

16. Golinelli D, Sanmarchi F, Guarducci G, Palombarini J, Benetti P, Rosa S, et al. Gender differences in healthcare utilization across Europe: evidence from the European Health Interview Survey. Health Policy. 2025;162:105448. doi: https://doi.org/10.1016/j.healthpol.2025.105448

17. Reis IFA, Lima LR, Funez MI, Funghetto SS, Costa MVG, Leite MM, et al. Predictive factors for diabetic neuropathy in older people treated in primary care. Rev Enf Ref. 2021;5(7):e20148. doi: https://doi.org/10.12707/rv20148

18. Hagen KM, Ousman SS. Aging and the immune response in diabetic peripheral neuropathy. J Neuroimmunol. 2021;355:577574. doi: https://doi.org/10.1016/j.jneuroim.2021.577574

19. Hicks C, Wang D, Windham B, Matsushita K, Selvin E. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep. 2021;11:98565. doi: https://dx.doi.org/10.1038/s41598-021-98565-w

20. Instituto Brasileiro de Geografia e Estatística (IBGE). Censo Demográfico 2022: população e domicílios: primeiros resultados [Internet]. 2022 [cited Nov 10, 2025]. Available from: https://censo2022.ibge.gov.br/

21. Gowtham S, Vm AE, Thozhanenjan I, Cm N, Narayanan K. Prevalence of diabetic peripheral neuropathy and its associated risk factors among patients with type 2 diabetes mellitus in the Chengalpattu district of Tamil Nadu. Cureus. 2025;17(5):e83586. doi: http://doi.org/10.7759/cureus.83586

22. Shiffman D, Louie JZ, Devlin JJ, Rowland CM, Mora S. Concordance of cardiovascular risk factors and behaviors in a multiethnic US nationwide cohort of married couples and domestic partners. JAMA Netw Open. 2020;3(10):e2022119. doi: https://doi.org/10.1001/jamanetworkopen.2020.22119

23. Fagundes CP, Wu EL. Biological mechanisms underlying widowhood’s health consequences: does diet play a role? Compr Psychoneuroendocrinol. 2021;7:100058. doi: https://doi.org/10.1016/j.cpnec.2021.100058

24. Ibrahim IAE, Alshahrani MFS, Alshahrani SNS, Alamri ANS, Alamri AMA, Alshahrani SF. Investigating awareness, risk factors, and management of diabetic peripheral neuropathy: an all-inclusive cross-sectional study in Saudi Arabia. J Pharm Bioallied Sci. 2025;17(Suppl):375-7. doi: https://doi.org/10.4103/jpbs.jpbs_177_25

25. Li C, Wang W, Ji Q, Ran X, Kuang H, Yu X, et al. Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: a nationwide cross-sectional study in mainland China. Diabetes Res Clin Pract. 2023;198:110602. doi: http://doi.org/10.1016/j.diabres.2023.110602

26. Davalos L, Callaghan BC, Muthukumar L, Thomas S, Reynolds EL, Smith AG, et al. The impact of diabetes and metabolic syndrome burden on pain, neuropathy severity and fiber type. Ann Clin Transl Neurol. 2025;12(7):1408-17. doi: https://doi.org/10.1002/acn3.70072

27. Zhou P, Zhou J, Li J, Qin L, Hu W, Zhang X, et al. Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Front Neurol. 2025;16:1564867. doi: https://doi.org/10.3389/fneur.2025.1564867

28. Bell DSH, Goncalves E. Alcohol consumption as a causator and/or an accelerator of neuropathy in people with diabetes is regularly overlooked. Diabetes Ther. 2021;12(10):2631-4. doi: https://doi.org/10.1007/s13300-021-01131-w

29. Fan Z, Liu Y, Xie H, Yang Q, Zhang G, Zhang P, et al. Analysis of risk factors for foot ulcers in diabetes patients with neurovascular complications. BMC Public Health. 2025;25(1):792. doi: https://doi.org/10.1186/s12889-025-21639-1

30. Neves RG, Saes MO, Duro SMS, Flores TR, Tomasi E. Inequalities in care for the people with diabetes in Brazil: a nationwide study, 2019. PLoS One. 2022;17(6):e0270027. doi: https://dx.doi.org/10.1371/journal.pone.0270027